from its primary site of action in mitochondria (Liu et transfected cell clones resistant to the neomycin analog G418, two showed homologous recombination at the al ., 1992a, 1992b) . The sequence predicts a polytopic membrane protein with twelve transmembrane domains anticipated site in the VMAT2 gene by Southern analysis using both 5Ј ( Figure 1B ) and 3Ј probes (data not shown). and no similarity to plasma membrane neurotransmitter transporters (Erickson et al., 1992; Liu et al., 1992b) .
Injection of these ES clones into blastocysts yielded multiple chimeras, and these were further bred with However, the sequence does show both structural and functional similarity to a class of bacterial antibiotic re-C57BL/6 animals to produce VMAT2 heterozygotes (ϩ/Ϫ). The heterozygotes were then mated with each sistance proteins, supporting a role in detoxification as well as signaling. Indeed, the normal neurotransmitter other to produce homozygous (Ϫ/Ϫ) animals. The knockout (Ϫ/Ϫ) mice lack VMAT2 by a variety of dopamine readily oxidizes to produce free radicals and may contribute to the selective degeneration of dopacriteria. Western analysis using a polyclonal antibody that we have raised to rat VMAT2 (Peter et al., 1995) mine cells that occurs in Parkinson's disease. Vesicular monoamine transport may thus protect against this enshows no detectable immunoreactive protein in membranes prepared from the homozygotes ( Figure 1C ). Hetdogenous toxin as well as exogenous toxins such as MPP ϩ . The sequence also defined a family of proteins erozygotes contain less immunoreactivity, suggesting a lack of compensation by the remaining normal allele, at that now includes two vesicular monoamine transporters (Erickson et al., 1992; Liu et al., 1992b) as well as least in terms of the level of protein.
Other synaptic vesicle proteins such as the vesicular acetylcholine an acetylcholine (ACh) transporter (VAChT; Alfonso et al., 1993) . Vesicular monoamine transporter 1 (VMAT1) transporter and synaptophysin show no generalized reduction, confirming the specificity of the defect in occurs in nonneural cells of the periphery, whereas VMAT2 occurs in neurons (Weihe et al., 1994; VMAT2. To determine whether the gene disruption has eliminated vesicular amine transport activity, we meaal., 1995) . Biochemical analysis of transport function in transfected cells has also shown that the two VMATs sured transport in the knockout animals. Membranes from VMAT2 Ϫ/Ϫ mice show the same transport function differ in their affinity for substrates, in their pharmacology (Peter et al., 1994) , and in their phosphorylation by as membranes from wild-type animals that have been treated with the potent inhibitor reserpine, confirming endogenous kinases (Krantz et al., 1997) . Overexpression of VMAT2 in rat pheochromocytoma PC12 cells the loss of VMAT2 activity ( Figure 1D ). Importantly, the results also indicate a lack of compensation by other increases quantal size ‫-3ف‬fold (Sun et al., unpublished data) . Similarly, overexpression of VAChT in cultured transport activities such as VMAT1, which occurs transiently in the brain during development (Hansson et al., Xenopus motor neurons increases quantal size 2-to 3-fold (Song et al., 1997) , suggesting that the expression 1996, Soc. Neurosci., abstract). VMAT2 ϩ/Ϫ heterozygous mice also show less transport activity than wild-type of vesicular transporters determines the filling of synaptic vesicles and the amount of neurotransmitter reanimals, but the low concentrations of 3 H-serotonin used for the assay do not provide a measure of the maximum leased.
To characterize the role of vesicular monoamine transrate of transport (V max ). To quantitate the reduction in VMAT2, we measured binding to tetrabenazine, another port in transmitter release, signaling, and behavior in vivo, we have disrupted the gene encoding the neuronal potent inhibitor of VMAT2 ( Figure 1E ). Brain membranes from VMAT2 homozygotes show no specific binding to isoform VMAT2. The mutant mice move little, feed poorly, and do not survive more than a few days after 3 H-tetrabenazine, whereas heterozygotes show 52% of the binding observed to membranes from wild-type litbirth. However, amphetamines promote locomotion, feeding, and survival, presumably by circumventing the termates.
Mice homozygous for disruption of the VMAT2 gene block to exocytotic monoamine release. The precise mode of monoamine release thus does not appear cruare born from heterozygote crosses at the expected Mendelian ratio of ‫,4/1ف‬ indicating survival through emcial for certain complex behaviors, consistent with the role of monoamines as neuromodulators. The analysis bryonic development. However, VMAT2 Ϫ/Ϫ animals show differences from wild-type and heterozygous littermates of VMAT2 heterozygotes also suggests that the expression of VMAT2 determines the rate of synaptic vesicle soon after birth. The homozygous animals are small and move relatively little ( Figure 2A ). However, they do move filling and the amount of monoamine released.
vigorously in response to mild pain (e.g., tail pinching), excluding simple paralysis. Homozygous mice feed Results poorly, with little if any milk visible in their stomachs, do not gain weight ( Figure 2B ), and die within the first To understand how vesicular transport influences week of life ( Figure 2C ). monoamine release and behavior, we disrupted the To determine whether the elimination of VMAT2 im-VMAT2 gene in mice. Transmembrane domain (TMD) pairs movement, feeding, and survival by interfering with 1 contains an aspartate required for transport activity neural development, we examined the brains of homozy- (Merickel et al., 1995) . Since the first protein-coding gous knockout mice. Although smaller than those of exon of the mouse VMAT2 gene encodes the entire wild-type littermates, the brains of VMAT2 Ϫ/Ϫ animals TMD1, we replaced this exon with a selectable marker show no gross disturbance in morphology. Staining with for resistance to neomycin and introduced the concresyl violet also shows normal cell populations in the struct, with 1.7 kb genomic DNA flanking the 5Ј end of forebrain and brainstem (data not shown). Since a disturthe marker and 4.9 kb flanking the 3Ј end ( Figure 1A) , bance in monoamine transmission might have a relatively selective effect on the development of monoamine into 129/SvJ embryonic stem (ES) cells. From 400 stably To construct the targeting vector, the selectable marker for resistance to neomycin PGK-neo was used to replace an Aat II-Pflm I restriction fragment that contained the entire first protein-coding exon. The location of 5Ј and 3Ј probes used for genotype analysis (cross-hatched boxes) are shown along with the predicted size of Bam HI and Pflm I restriction fragments in the wild-type (wt) and mutant alleles. The shaded box indicates pBluescript vector sequences. Restriction sites for Pflm I are indicated by PI, sites for Bam HI by BI, Sac I by SI, Aat II by AII, and Pst I by Pst. (B) Southern analysis of genomic DNA from the offspring of a cross between two VMAT2 heterozygous (ϩ/Ϫ) mice. Tail genomic DNA was digested with Pflm I, separated by electrophoresis through agarose, blotted to nylon, and hybridized to the 3Ј probe described in (A). Both bands occur in the heterozygotes (ϩ/Ϫ), whereas only the 6.2 kb wt band appears in the wild-type (ϩ/ϩ) mice and only the 11.2 kb mutant band in the homozygous knockout (Ϫ/Ϫ) mice. Southern analysis was also performed using digestion with Bam HI and hybridizion with the 5Ј probe described in (A) (data not shown). A total of 172 mice born from crosses between VMAT2 heterozygotes yielded the following genotypes: ϩ/ϩ, 23.8%; ϩ/Ϫ, 49.4%; and Ϫ/Ϫ, 26.7%. (C) Western analysis of membrane vesicles prepared by differential centrifugation from the brains of wild type (ϩ/ϩ), heterozygous (ϩ/Ϫ), and knockout (Ϫ/Ϫ) mice. Membrane vesicles from the brains of newborn mice (100 g protein) were separated by electrophoresis through polyacrylamide and transferred to nitrocellulose, and the blot was incubated with the indicated antibodies. Incubation with the VMAT2 antibody shows no detectable immunoreactivity in knockout animals and reduced staining in heterozygous relative to wild-type mice. Staining with the antibodies against two synaptic vesicle proteins, the vesicular acetylcholine transporter (VAChT) and synaptophysin (p38), shows no difference among cell populations, we immunostained for tyrosine hydroxet al., 1981; Fishell and van der Kooy, 1987) occur in both wild-type and VMAT2 Ϫ/Ϫ animals. Direct examination of ylase (TH), the rate-limiting enzyme in catecholamine biosynthesis. Dopamine neurons in the substantia nigra the striatal patch-matrix system (Gerfen, 1992) by immunostaining for the opioid receptor also shows no differof VMAT2 Ϫ/Ϫ mice ( Figure 3B ) show no clear difference from those in wild-type animals ( Figure 3A ). In addition, ence between wild-type ( Figure 3E ) and knockout animals ( Figure 3F ). Thus, vesicular monoamine transport TH-immunoreactive fibers in the striatum of knockout mice ( Figure 3D ) show no substantial difference from and hence exocytotic release of monoamines do not appear to be required for normal development of the those in wild-type littermates ( Figure 3C ). Dopamine islands that form transiently during development (Graybiel mesostriatal projection. tonin in cell bodies but not processes. We also quantitated brain monoamines directly by high pressure liquid To characterize the defect in monoamine transmission chromatography (HPLC). The brains of homozygous in VMAT2
Ϫ/Ϫ mice, we examined brain monoamines dimice show extremely low monoamines ( Figure 4E ), with rectly. Immunostaining for serotonin revealed no detectdopamine at ‫%5.1ف‬ of wild-type levels, norepinephrine able reactivity in the cortex of knockout mice (Figure at ‫,%6ف‬ and serotonin at ‫.%1ف‬ The results support the 4B), whereas wild-type animals contain profuse immuprevious impression that an extremely large proportion noreactive fibers ( Figure 4A ). However, the cell bodies of brain monoamines in normal animals occurs in the of serotonergic neurons in the raphe of VMAT2 Ϫ/Ϫ homovesicular storage pool. The levels of dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and zygotes still contain some immunoreactivity ( Figure 4D ), 
VMAT2
Ϫ/Ϫ mice also has little effect on dopamine levels was considerably less than that of VMAT2 ϩ/ϩ littermates. Scale bar, but increases serotonin to wild-type levels. Thus, metab-exocytotic mechanism such as flux reversal by a plasma membrane transporter. To examine monoamine storage and release directly, 5-hydroxyindolacetic acid (5-HIAA) appear normal in the mutant mice ( Figure 4E ) despite the extremely low levels we used primary midbrain cultures. Although the knockout mice do not survive for more than a few days after of monoamine transmitters, suggesting rapid metabolism of the transmitter that cannot be stored in vesicles.
birth, 4-week-old midbrain cultures from these animals show numbers of TH-positive cells at least as great To assess the role of metabolism in the low monoamine levels of VMAT2-deficient mice, we have used as those from wild-type and heterozygous littermates ( Figure 6A ). The morphology of dopamine neurons from inhibitors of monoamine oxidases (MAO) A and B, the principal enzymes involved in monoamine degradation VMAT2 Ϫ/Ϫ homozygotes also appears indistinguishable from that of cells from normal littermates ( Figure 6A ). Similar to monoamine levels in the brain, total dopamine levels in the knockout cultures show a dramatic reduction ( Figure 6B ). To examine exocytotic release from the midbrain cultures, we have used K ϩ -evoked depolarization for 2 min and measured the dopamine released into the medium. Whereas cultures from wild-type animals show substantial release of dopamine, cultures from the VMAT2 Ϫ/Ϫ mice show essentially no release ( Figure 6C ), confirming the requirement for vesicular transport to enable exocytotic release of transmitter. We have also used the midbrain cultures to determine the dependence of amphetamine action on VMAT2. Exposure to 10 M D-amphetamine for 30 min induces dopamine release from the midbrain cultures of VMAT2 Ϫ/Ϫ mice ( Figure 7A ), indicating that VMAT2 is not required for the action of this psychostimulant, at least in cells lacking VMAT2. On the other hand, cultures from the knockout animals release only ‫%53ف‬ as much dopamine as cultures from wild-type animals, demonstrating that VMAT2 and hence the vesicular pool nonetheless contribute the majority of dopamine released by amphetamine. Interestingly, the amount of dopamine not released by amphetamine (total minus released) appears to correlate with VMAT2 gene dosage ( Figures 7A and 7B ), suggesting that the transport activity also reduces net efflux from vesicles.
Since VMAT2 gene disruption reduces total brain monoamine and midbrain culture dopamine to Ͻ5% of wild-type levels, it is remarkable that amphetamine continues to induce release of greater than one-third as much dopamine from the knockout cultures as from wild-type cultures. Interestingly, amphetamine increases the total amount of dopamine stored in and released from midbrain cultures of wild-type mice by ‫-5.2ف‬fold gesting that flux reversal across the plasma membrane Neurons derived from the midbrain of newborn VMAT2 ϩ/ϩ and promotes synthesis by reducing the feedback inhibition VMAT2 Ϫ/Ϫ mice were grown in culture for 4 weeks and immunostained for tyrosine hydroxylase (TH) (Mena et al., 1997) . The THof cytoplasmic dopamine on TH (Zigmond et al., 1989;  immunoreactive cells from VMAT2 Ϫ/Ϫ mice show no differences in Kumer and Vrana, 1996) on TH. The ability of amphetamine to induce substantial (n ϭ 9), and VMAT2 Ϫ/Ϫ (n ϭ 6) mice were maintained in culture for dopamine release from the VMAT2 knockout cultures at http://www.neuron.org/supplemental/19/6/1271), feed better, and increase slightly in weight. Although they never attain the same weight as wild-type or heterozygous littermates and eventually die, amphetamine injection clearly increases the survival of VMAT2 Ϫ/Ϫ animals into the third week after birth. Amphetamine can thus circumvent the defect in vesicular release of monoamine transmitters and promote complex behavioral phenomena such as locomotion and feeding, but it does not restore the knockout mice to normal.
We have also analyzed VMAT2 ϩ/Ϫ heterozygotes to determine how the level of transporter expression influences transmitter release and behavior. The heterozygotes appear indistinguishable from wild-type littermates throughout the period of observation. Indeed, they move vigorously, feed well, and grow normally (Figures 2B and 2C ). However, VMAT2 ϩ/Ϫ heterozygotes contain 58% as much dopamine, 77% as much norepinephrine, and 66% as much serotonin as wild-type animals ( Figure 4E ), indicating that a 50% reduction in VMAT2 protein expression produces a large reduction in monoamine stores. VMAT2 thus regulates the amount of neurotransmitter stored in vivo. In addition, midbrain cultures from heterozygous mice contain only ‫%57ف‬ as much dopamine as cultures from wild-type littermates and release 47% as much dopamine in response to depolarization for 2 min with elevated K ϩ ( Figures 6B  and 6C ). The regulated release of dopamine during continuous stimulation thus depends on VMAT2 expression, suggesting that VMAT2 determines the filling of recycling synaptic vesicles. If VMAT2 regulates the rate of analysis and ‫%05ف‬ as much binding to 3 H-tetrabenazine. The failure to observe either compensatory upregulation of VMAT1 in the absence of VMAT2 or of the strongly reduces the effect of amphetamine on feeding ( Figure 8A) . Thus, the nonvesicular release of catecholaremaining wild-type allele in the heterozygotes suggests that cell identity rather than monoamine neurotransmismine promoted by amphetamine can sustain certain complex behaviors in the absence of exocytotic release.
sion determine both the isoform and level of VMAT expressed. Since poor feeding and reduced growth presumably account for the failure of VMAT2 Ϫ/Ϫ mice to survive, we The absence of exocytotic monoamine release in VMAT2 Ϫ/Ϫ mice has no discernible effect on brain develthen injected the knockout mice with the same dose of D-amphetamine three times a day. As shown in Figure  opment . The animals are born in the expected Mendelian proportions from heterozygote crosses and standard 8B, knockout animals injected with amphetamine survive substantially longer than knockout mice injected histological stains reveal no major abnormality in brain structure. Further, immunostaining of the brainstem for with saline. Indeed, they move more, show more directed movements such as crawling in the first week TH shows abundant catecholamine neurons with normal morphology. Mesostriatal dopamine projections also and walking in the third week (see supplemental video has no effect on their appearance, strongly suggesting their independence of monoamine neurotransmission, unless VMAT1 compensates for the absence of VMAT2 during a critical period early in embryonic development (Hansson et al., 1996, Soc. Neurosci., abstract) . Consistent with the observed independence from vesicular monoamine transport, dopamine-deficient mice also show normal development of dopamine neurons and their striatal projections (Zhou and Palmiter, 1996) . The formation of monoamine connections may thus depend either on signaling by transmitters other than monoamines or on intrinsic developmental mechanisms.
Although the brain appears to develop normally in VMAT2 mutant mice, the animals survive for only a few days after birth. Nonetheless, they still live longer than mice deficient in TH that cannot produce catecholamines and mice deficient in dopamine ␤-hydroxylase that cannot produce norepinephrine, which largely die in utero. (Thomas et al., 1995; Zhou et al., 1995) . Since elimination of vesicular transport also interferes with the release of catecholamines, the ability of VMAT2 mutants to survive past birth suggests that these transmitters are released through a different mechanism, possibly through VMAT1 expression, which persists into adulthood in nonneural cells such as chromaffin cells of the adrenal medulla (Weihe et al., 1994; Peter et al., 1995) . In contrast, the biosynthetic enzymes occur as only a single isoform, resulting in catecholamine dysfunction in both neural and nonneural tissues of knockout mice. Indeed, the embryonic lethality of knockouts in the biosynthetic enzymes may result from a disturbance in the peripheral cardiovascular system (Thomas et al., 1995; mine-deficient mice (Zhou and Palmiter, 1996) . The be-D-amphetamine coadministered with the plasma membrane uptake havioral deficit in VMAT2 mutant mice resembles that inhibitor nomifensine (10 mg/kg), and normal saline were alternately observed at a slightly greater age in dopamine-deficient administered to neonatal VMAT2 Ϫ/Ϫ mice (n ϭ 28). The injections animals, with reduced movement and feeding behavior,
were initiated within 24 hr after birth and repeated twice daily for supporting the results of classic pharmacological studup to 7 days after birth. One hour after administration, the mice were scored for either active suckling or the presence of milk in the ies showing that dopamine stimulates locomotion and stomach. Feeding behavior was greatly enhanced by amphetamine mediates the rewarding action of food (Wise, 1990;  compared to saline. This increased feeding was blocked by the Koob, 1992) . However, the requirement of VMAT2 funcspecific plasma membrane catecholamine transport inhibitor nomition for norepinephrine and serotonin as well as dopafensine.
mine release from neural cells may account for onset (B) Amphetamine increases survival in VMAT2-deficient mice. At birth, VMAT2 Ϫ/Ϫ mice were alternately assigned to receive either of the syndrome immediately after birth in the VMAT2 D-amphetamine (AMPH; 10 mg/kg, subcutaneously; n ϭ 13) or normutants rather than at 2 weeks as in the dopaminemal saline (n ϭ 13), both administered three times per day. Half the deficient mice.
mice that had received amphetamine survived to the third week
The dramatic reduction in brain monoamines obafter birth, whereas none of the mice who had received saline surserved in VMAT2-deficient animals reflects the absence vived past the first week. Mean survival also increased from 3.2 Ϯ 0.5 days in the saline-treated to 10.7 Ϯ 1.8 days in the amphetamineof a storage pool and supports previous work sugtreated animals (p Ͻ 0.001). Amphetamine increased spontaneous gesting that the bulk of brain transmitter resides in synactivity and weight as well, with saline-treated mice reaching 1.36 Ϯ aptic vesicles. Nonetheless, the level of monoamine me-0.05 g, whereas amphetamine-treated littermates reached 2.26 Ϯ tabolites remains similar to that of wild-type animals. The relatively high level of metabolites suggests that the failure to package transmitter into synaptic vesicles increases the time spent in the cytoplasm and hence the appear normal, including the presence of dopamine isaccessibility to enzymes such as monoamine oxidase lands (Graybiel et al., 1981; Fishell and van der Kooy, (Napolitano et al., 1995) . Indeed, inhibition of MAO-A 1987) and opioid receptor-positive patches (Gerfen, increases serotonin levels dramatically in VMAT2 knock-1992). Although these structures presumably reflect out mice, indicating a central role for MAO-A in the finely tuned mechanisms that govern the development of striatal circuitry, the absence of dopamine release metabolism of serotonin. The increased immunoreactive serotonin in cell bodies but not processes of raphe neuamphetamine to induce substantial dopamine release even in the absence of vesicular stores. Amphetamine rons in untreated VMAT2 Ϫ/Ϫ mice may result from reduced metabolism at this site (Westlund et al., 1988;  thus appears to have a greater effect on dopamine synthesis when the vesicular store of transmitter is de- Saura et al., 1992) or by less prominent feedback inhibition of tryptophan hydroxylase (Boadle-Biber, 1993) .
pleted, possibly because the reduced efflux from vesicles together with increased efflux across the plasma However, dopamine levels do not increase even after inhibition of both MAO-A and -B, suggesting that addimembrane reduces cytoplasmic concentrations to extremely low levels and essentially eliminates feedback tional mechanisms prevent accumulation. The absence of an increase in metabolites in VMAT2 Ϫ/Ϫ mice over wild inhibition on the rate-limiting biosynthetic enzyme TH (Zigmond et al., 1989; Kumer and Vrana, 1996) . In additype suggests a down-regulation of biosynthesis due to feedback inhibition of TH (Spector et al., 1967) , although tion, the absence of vesicular monoamine transport may cause the accumulation of cytoplasmic transmitter to an overall increase in metabolic flux through the pathway is also possible. Indeed, the increased cytoplasmic levels that promote efflux across the plasma membrane. Amphetamine action may thus require vesicular stores concentrations of monoamine may promote nonvesicular release by the reversal of plasma membrane transand hence VMAT2 function in wild-type animals to elevate cytoplasmic monoamines and promote efflux. porters even in the absence of drugs such as amphetamine. The increased motor activity observed after Nonetheless, the extraordinary ability of amphetamines to induce release even in the absence of vesicular stores administration of the MAO inhibitors supports this possibility.
may account for persistent effects even after repeated administration and hence underlie their potential for A variety of conditions such as disruption of the plasma membrane dopamine transporter dramatically abuse (Robinson, 1991; Seiden et al., 1993; Pierce and Kalivas, 1995; Melega et al., 1995) . reduce brain monoamines but do not impair survival (Giros et al., 1996) , suggesting that VMAT2 disruption
The ability of amphetamine to induce dopamine release from VMAT2-deficient neurons also enabled us to blocks monoamine release as well as reduces stores. Using primary midbrain cultures, K ϩ -evoked depolarizaassess the biological effects of nonvesicular release. Administration of L-DOPA to patients with Parkinson's tion induces release of dopamine from wild-type but not from homozygous mutant cultures, confirming the disease has suggested that tonic rather than phasic release of dopamine may suffice to preserve motor conrequirement of vesicular transport for exocytotic release. Amphetamine continues to induce dopamine retrol (Birkmayer and Hornykiewicz, 1961; Cotzias et al., 1969) . However, the dopamine derived from exogenous lease from mutant cultures, indicating that the expression of VMAT2 and the presence of vesicular stores is L-DOPA presumably enters the remaining dopamine terminals from which it undergoes exocytotic release not required for this in vitro measure of drug action, at least in VMAT2-deficient cells. (In wild-type cells, VMAT2 (Pothos et al., 1996) . The progressive loss of dopamine neurons in the disease and the reduced ability to store may be essential to promote vesicular efflux, increase cytoplasmic monoamine, and so promote efflux across and release dopamine in a regulated manner may indeed underlie the eventual failure of L-DOPA replacement the plasma membrane.) In cells lacking VMAT2, flux reversal by plasma membrane monoamine transporters therapy (Brannan et al., 1996) . To determine whether tonic monoamine release can support complex behavapparently suffices to mediate the release of monoamines by amphetamine, consistent with both pharmaioral phenomena, we took advantage of the ability of amphetamine to induce nonvesicular monoamine recologic and genetic studies (Di Chiara and Imperato, 1988; Rudnick and Wall, 1992; Sulzer et al., 1993 ; Giros lease in the absence of VMAT2. Systemic administration to newborn VMAT2 Ϫ/Ϫ mice increases directed locomoet al., 1996) . Nonetheless, the amount of dopamine released by amphetamine from the mutant cultures was tor behavior, including crawling in the first few days after birth and walking in the third week. In addition, ‫%53ف‬ that released from wild-type cultures, indicating that the majority of dopamine is released from the vesicamphetamine increases suckling and the presence of milk in the abdomen. The catecholamine reuptake inhibiular compartment, at least under normal conditions (Florin et al., 1995; Sulzer et al., 1996) . The observation that tor nomifensine blocks these phenomena, indicating that nonvesicular release through a plasma membrane the amount of dopamine not released by amphetamine also correlates with VMAT2 gene dosage may indicate transporter can induce certain complex behaviors and phasic release is not required for these phenomena. The that VMAT2 actually opposes the action of amphetamine, although residual lumenal dopamine bound to a ability of nomifensine to block amphetamine stimulation of these behaviors also strongly suggests that they are matrix inside the vesicle could limit vesicular efflux in wild-type and to a lesser extent heterozygous mice. mediated by catecholamines. Clorgyline stimulates similar behaviors to amphetamine but elevates only serotoIn light of the drastically reduced dopamine stores observed in both the brains and cultures of VMAT2 Ϫ/Ϫ nin. However, catecholamine efflux induced by clorgyline may not result in a net increase in steady-state levels mice, the ability of amphetamine to release relatively large amounts of dopamine is remarkable. Midbrain culdue to metabolism unrelated to MAO. Although amphetamine prolongs the survival of tures from both wild-type and mutant mice show an increase in dopamine after exposure to amphetamine VMAT2 mutant mice, they still do not grow normally and die in the third week of life. The inability of amphetamine relative to depolarization. However, the increase in mutant cultures is 10-fold greater than the increase in wildto rescue the VMAT2-deficient phenotype completely may result from insufficiently frequent administration, type cultures, apparently accounting for the ability of reduced efficacy with repeated use, or the inadequacy These results support recent studies of vesicular acetylcholine transport in a culture model of the neuromusof nonvesicular monoamine release to sustain more complex behaviors required for survival beyond 2-3 cular junction. In this system, elevated expression of VAChT increased quantal size (Song et al., 1997) , preweeks of age. It also remains unclear whether amphetamine improves viability by releasing monoamines from sumably because this protein also influences the rate of synaptic vesicle filling. The expression of vesicular central or peripheral sympathetic stores. Nonetheless, the ability to prolong survival of VMAT2 Ϫ/Ϫ animals into neurotransmitter transport proteins thus limits vesicle filling in the presence of wild-type as well as reduced the third week after birth should enable analysis of such postnatal developmental events as barrel field formatransporter expression. This predicts that changes in activity and hence vesicle cycling will influence the tion, in which the plasma membrane serotonin transporter and VMAT2 have both been implicated (Lebrand amount of transmitter stored per vesicle. Elevated VAChT expression also increased the frequency of reet al., 1996) .
In addition to its essential role in exocytotic release, lease (Song et al., 1997) , possibly because the larger quantal size facilitated detection. However, increased the level of VMAT2 expression influences the amount of monoamine stored and released. Although the VMAT2
VAChT may also recruit synaptic vesicles not previously capable of storing neurotransmitter, a possibility supheterozygotes appear normal in behavior, growth and survival, their brains contain substantially less dopamine ported by the observation that unstimulated wild-type midbrain cultures store substantially more dopamine and serotonin than wild-type animals. VMAT2 thus determines the storage of these transmitters. If synaptic than VMAT2 heterozygote cultures even though the unstimulated state should permit greatly increased time vesicles have adequate time to fill with neurotransmitter, the level of VMAT expression should make little differfor vesicle refilling. In summary, the results show that VMAT2 is essential ence to the amount of transmitter stored at equilibrium. However, if synaptic vesicles do not have adequate time for exocytotic monoamine release but not release induced by amphetamine, at least in the absence of vesicto fill, VMAT2 expression would influence the amount of transmitter stored. ular monoamine stores. Indeed, amphetamine partially rescues the phenotype of VMAT2-deficient mice, indiRecent studies have demonstrated rapid recycling of synaptic vesicles within 1-2 min after exocytosis (Ryan cating that nonvesicular release suffices for behavior dependent on monoamines, consistent with their role et Lagnado et al., 1996) . If each synaptic vesicle contains ‫0005ف‬ molecules of serotonin (Bruns and Jahn, as neuromodulators. The analysis of heterozygous mice also demonstrates that the level of VMAT2 expression 1995), it would take a single VMAT2 protein with a turnover number of 5/s at 29ЊC (Peter et al., 1994) ‫51ف‬ influences the storage and release of monoamines, presumably because the rate of synaptic vesicle recycling min to fill the vesicle at saturating concentrations of transmitter. Although the rate would be greater at 37ЊC, exceeds the rate of refilling with transmitter but possibly because transporter expression also determines the and the turnover of dopamine by VMAT2 is faster than that of serotonin (Finn and Edwards, 1997) , the filling number of vesicles capable of storing transmitter. would still take several minutes at saturating substrate concentrations. In addition, the cytoplasmic concentra-
Experimental Procedures
tion of monoamines appears considerably lower than Production of VMAT2 Mutant Mice the Km for transport (Perlman and Sheard, 1982) , making Using the rat VMAT2 cDNA as a probe for hybridization, several the time required to fill the vesicle considerably longer. the VMAT2 locus were microinjected into C57BL/6 blastocysts. Male Histology Mice aged 0-7 days after birth were anesthetized and perfused chimeras derived from these blastocysts were mated with C57BL/6 females and germline transmission was assessed by coat color. Tail for 15 min with cold 4% paraformaldehyde-4% sucrose in 0.1 M phosphate buffer (pH 7.4). The brains were then dissected and imgenomic DNA was used to genotype the agouti offspring, either by Southern analysis using the 3Ј probe described above or by PCR. mersed in the same fixative overnight at 4ЊC, cryoprotected in increasing concentrations of sucrose (10%, 20% and 30%), frozen in One pair of primers (5Ј-CATCGTGTTCCTCGCGCTGC-3Ј and 5Ј-GGGATGCTGTCACCTGGG-3Ј) was designed to amplify a 181 bp O. C. T. (Tissue-Tek), and sectioned at 15-30 m using a cryostat. All histologic analysis involved comparison of VMAT2 Ϫ/Ϫ mice with fragment in the wild-type but not the mutant allele, whereas a second primer pair (5Ј-CCGCTCCCGATTCGCAGCG-3Ј and 5Ј-GCAGCAGC wild-type (ϩ/ϩ) mice from the same litter. For immunocytochemistry, brain sections were rinsed in phos-TTAGCACACTGG-3Ј) was designed to amplify a 292 bp fragment in the mutant but not the wild-type allele. Heterozygous mice were phate buffered saline (PBS), pretreated with 0.3% H 2O2 in PBS for 30 min, blocked in PBS containing 5% normal goat serum and 0.3% then mated to generate homozygous mutant mice.
Triton X-100 for 1 hr, and then incubated at 4ЊC overnight in the same buffer with either antibodies to TH (Eugene Tech), opioid Western Analysis receptor (a generous gift of Chris Evans, UCLA), or serotonin To prepare membrane vesicles, the brains of newborn mice were (Incstar) at dilutions of 1:1000, 1:100, and 1:25,000, respectively. dissected on ice, frozen immediately, and stored in liquid nitrogen.
After washing in PBS containing 1% normal goat serum and 0.3% Using a chilled porcelain mortar and pestle, the brains were ground Triton X-100 (PBT) three times for 10 min each, the sections were to a fine powder and dissolved in ‫5ف‬ ml cold 0.32 M sucrose, 10 incubated for 30 min at room temperature with biotinylated goat mM HEPES-KOH (pH 7.4; SH buffer) containing 5 mM Mg EGTA, anti-rabbit secondary antibody (Vector) diluted 1:200 in PBT, 0.4 mM phenylmethylsulfonyl fluoride, 10 M leupeptin, 2 g/ml washed three times again in PBT, and incubated for 30 min with an pepstatin A, 2 g/ml E64, and 2 g/ml aprotinin (homogenization avidin-biotin complex conjugated to horseradish peroxidase (Vecbuffer). The samples were then disrupted with a Teflon homogenizer tor), again in PBT. The sections were then washed twice in PBT and and the debris sedimented at 1600 ϫ g for 10 min at 4ЊC. Membrane once in PBS, and the deposits were visualized with 0.04% 3Ј,3Ј-vesicles in the supernatant were then collected by sedimentation diaminobenzidine and 0.0001% H 2O2, using 0.3% NiSO4 to enhance at 175,000 ϫ g for 1 hr at 4ЊC. The pellet was resuspended in ‫002ف‬ the reaction. l homogenization buffer and either used immediately or stored at Ϫ70ЊC. The protein concentration of the sample was determined using the Bradford assay (Bio-Rad).
Quantitation of Brain Monoamines For Western analysis, 100 g membrane protein extracted from Whole brains from neonatal mice were dissected on ice and disthe brains of wild-type, heterozygous, and homozygous mice was rupted with a Teflon homogenizer in 1 ml cold 0.1 N perchloric acid separated by electrophoresis through 10% polyacrylamide and and 0.1 mM EDTA. The extracts were then sedimented at 16,000 ϫ g transferred to nitrocellulose. The blots were then incubated with a for 20 min at 4ЊC, and the supernatant was collected and stored at polyclonal, affinity-purified, anti-peptide antibody (at a dilution of Ϫ70ЊC. Protein concentrations were determined using the Bradford 1:1000) that we have previously raised to rat VMAT2 (Peter et al., assay (BioRad). 1995) . Since the antibody recognizes the C terminus of VMAT2, it Monoamines and metabolites were measured using high perforhas the potential to detect forms of the protein truncated at the N mance liquid chromatography coupled with electrochemical detecterminus that might persist despite the gene disruption. As a control, tion (HPLC-EC) on an ESA Coulochem II detector equipped with a the blots were also incubated with a polyclonal antibody to the rat model 5011 analytical cell (ESA) set at an applied potential of 400 vesicular acetylcholine transporter (Gilmor et al., 1996) and with a mV and a Velosep RP-18 column (Applied Biosystems). The mobile monoclonal antibody to rat synaptophysin (p38; Sigma), both diluted phase contained 6.9 g/l NaH2PO4·H2O, 80 mg/l EDTA, 750 mg/l hep-1:5000. After incubation with the primary antibody, the blots were tasulfonic acid, and 4% methanol, adjusted to pH 3.6 with phosincubated with the appropriate secondary antibodies conjugated to phoric acid. Norepinephrine, DOPAC, 5-HIAA, dopamine, HVA, and peroxidase and the deposits visualized by enhanced chemiluminesserotonin were measured in 100 l samples from the whole brain cence (Amersham).
homogenates injected in a 200 l injection loop. The neurochemicals eluted in the above order and the total processing time was 25 min. The chromatography peaks of interest were compared to 10 pg/l Transport Measurement external standards injected in the HPLC on a daily basis. Transport assays were initiated by adding membrane extracts (50 g protein) to 200 l SH buffer containing 4 mM KCl, 2.5 mM MgSO4, 4 mM ATP, and 20 nM Postnatal mouse midbrain cultures were established as previously varying time intervals and terminated by dilution into 3 ml cold SH described (Mena et al., 1997) , except that the serum-free medium buffer followed by filtration through Supor 200 membranes (Gelman).
was supplemented with 10 ng/ml glial-derived neurotrophic factor Filters were dried and the bound radioactivity measured by scintilla-(Intergen) and cortical astrocyte monolayers were derived from tion counting in 2.5 ml of cytoscint (ICN). Background uptake was Sprague-Dawley rats (Rayport et al., 1992) . Briefly, the ventral middetermined at 0ЊC for 0 min. Transport activity was calculated using brain from 0-24 hr neonatal mice was dissected, the tissue from a 2 min time point during which the rate of uptake remained linear each animal dissociated in papain for 2 hr in separate vials, and (data not shown). The activity was measured using at least three 80,000 cells per culture plated on the astrocyte monolayer. Each different membrane preparations for each genotype.
animal yielded two to three cultures. One day after plating, cultures were treated with 6.6 ng/ml 5-flurodioxyuridine in 16.4 ng/ml uridine to suppress cell division. All experiments compared cultures derived Tetrabenazine Binding Tetrabenazine binding was initiated by adding membrane extracts from the same litter. TH staining was performed as previously described (Mena et al., 1997) . For cell counts, all TH-stained cell bodies (80 g protein) to 200 l SH buffer containing 5 nM 3 H-dihydrotetrabenazine (Amersham), either with or without excess unlabeled tetrain the dish were counted using differential interference contrast (DIC) optics in an inverted microscope. benazine (100 M). The reactions were incubated at 29ЊC for 20 min and terminated by dilution into 4 ml cold SH buffer containing 125
In unstimulated primary midbrain cultures, dopamine levels were measured in both the medium and perchloric acid cell extracts M unlabeled tetrabenazine, followed by filtration through Supor 200 membranes (Gelman). Filters were dried and the bound radioacusing HPLC with electrochemical detection, and the values were combined to yield total dopamine. For depolarization-evoked retivity measured by scintillation counting in 2.5 ml of cytoscint (ICN). Background binding was determined using the reaction solution lease of dopamine from primary midbrain neurons, the cultures were incubated in elevated KCl (40 mM KCl, 112 mM NaCl, 1 mM NaH 2PO4, alone without added membrane extracts. Tetrabenazine binding was measured using at least three different membrane preparations 10 mM HEPES, 1.2 mM CaCl 2, 1 mM MgCl2, and 25 mM glucose [pH 7.4]) for 2 min, the medium was collected immediately, and for each genotype.
